Chapter 19 - The civil cases
There were several legal tracks.
Not one giant lawsuit.
Lucas pursued claims related to unauthorized use of his stored reproductive material.
I pursued claims involving lack of informed consent, fertility-clinic negligence, and misrepresentation.
Grant had potential claims too because he consented to one donor and received another, though his later concealment complicated damages and credibility.
The clinic’s successor entity argued:
Adrian acted outside policy.
Plaintiffs answered:
The laboratory accepted a relabeled sample without completed documentation.
Both could be true.
The matter settled after extensive mediation.
Confidential financial amounts would normally remain confidential.
For the purposes of the story, what mattered was structure.
Lucas received substantial compensation.
Maddie received a protected fund for future counseling, identity-related needs, and medical-genetic review.
I received reimbursement of treatment-related damages, legal costs, and additional settlement compensation.
Grant’s claim resolved separately for a smaller amount because of his later knowledge and delayed reporting.
No $100 million windfall.
No clinic bankruptcy.
The successor company remained open under stricter procedures.
Independent audit.
Barcode controls.
Dual verification.
No physician override of donor-consent documentation.
Regulator monitoring.
Boring reforms.
May you like
Exactly what reproductive medicine needs when trust fails.
────────────────────
